Drugs Manufacturer GSK Dissolves into Haleon Kenya

GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya Limited, marking a new era in its operations, effective March 14, 2025.

Haleon, was launched as an independent consumer health company on 18 July 2022, following its formal demerger from GSK. Today, Haleon is the home of trusted brands such as Sensodyne, Panadol, Eno and Scott’s Emulsion – products relied upon by millions globally to improve everyday health.

“This transition is more than a name change; it’s a reaffirmation of our commitment to delivering high quality, science-led health solutions tailored for Kenyan consumers. As Haleon, we are strengthening our focus on innovation by developing products that combine trusted science with deep human understanding to meet the evolving healthcare needs of Kenyans,” said Mark Pfister, Haleon General Manager for Sub-Saharan Africa.

“We are also expanding our local manufacturing capabilities, ensuring greater accessibility to essential health products while maintaining the highest quality of standards for the betterment of Kenya.”

Haleon Kenya Limited operates in a state-of-the-art production facility at Likoni Road, Nairobi. This site plays a crucial role in the country’s oral healthcare and pain relief landscape, producing millions of units annually of leading brands such as Sensodyne,  Aquafresh and Panadol. Beyond meeting local demand, the facility serves as a regional hub, exporting to seven East African markets and South Africa.

“As we transition from GSK to Haleon, the packaging artwork on products will gradually evolve – from featuring the GSK logo to no logo, and eventually to the Haleon logo. Consumers may notice branding differences across various assets or even among different packages of the same product on shelves,” said Mark Pfister, Haleon General Manager for Sub-Saharan Africa.

“While there may be temporary variations in branding across different assets and product packs, Haleon’s commitment to delivering the highest standards of quality remains unchanged. Importantly, this legal name change will not have any impact on daily operations, product manufacturing, or staffing. Haleon remains fully committed to its employees and ensuring smooth business continuity.”

In 2024, Haleon Kenya Limited achieved Net Carbon Zero (NCZ) certification. Earlier this year, it also received Alliance for Water Stewardship and True Waste certifications, reinforcing its commitment to sustainable operations demonstrating Haleon’s commitment to environmental stewardship.

A significant step in this sustainability journey is Haleon’s investment in solar energy. The Likoni Road facility is powered by solar panels, reducing reliance on non-renewable energy sources and significantly reducing its carbon footprint.

At Haleon, we believe in empowering Kenyans to take control of their health through self-care. By combining trusted science with deep human understanding, we are not just delivering quality health solutions – we are easing the burden on Kenya’s healthcare system and shaping a healthier future for all.

> Equity Bank Founder Teaches MBAs a Lesson in Banking Business